Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex proteins. Enhancing these processes involves adjusting various parameters, including cell line engineering, media composition, and bioreactor settings. A key goal is to increase antibody production while lowering production costs